The role of adipose-derived inflammatory cytokines in type 1 diabetes

Reference

• Lehuen A, Diana J, Zaccone P, Cooke A. Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol 2010; 10:501-13; PMID:20577267; http://dx.doi.org/10.1038/nri2787
   PubMed Web of Science ®Google Scholar
• American Diabetes, A. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34 Suppl 1:S62-69; PMID:21193628
   PubMedGoogle Scholar
• Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19:433-42; PMID:18256353; http://dx.doi.org/10.1681/ASN.2007091048
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006; 6:772-83; PMID:16998510; http://dx.doi.org/10.1038/nri1937
   PubMed Web of Science ®Google Scholar
• Greenberg AS, Obin MS. Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 2006; 83:461S-465S; PMID:16470013
   PubMed Web of Science ®Google Scholar
• Odegaard JI, Chawla A. Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harbor Perspectives Med 2012; 2:a007724; http://dx.doi.org/10.1101/cshperspect.a007724
   PubMed Web of Science ®Google Scholar
• Rocha VZ, Folco EJ. Inflammatory concepts of obesity. Int J Inflam 2011; 2011:529061; PMID:21837268; http://dx.doi.org/10.4061/2011/529061
   PubMedGoogle Scholar
• Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003; 26:2442-50; PMID:12882876; http://dx.doi.org/10.2337/diacare.26.8.2442
   PubMed Web of Science ®Google Scholar
• Gesta S, Blüher M, Yamamoto Y, Norris AW, Berndt J, Kralisch S, Boucher J, Lewis C, Kahn CR. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A 2006; 103:6676-81; PMID:16617105; http://dx.doi.org/10.1073/pnas.0601752103
   PubMed Web of Science ®Google Scholar
• Tchkonia T, Lenburg M, Thomou T, Giorgadze N, Frampton G, Pirtskhalava T, Cartwright A, Cartwright M, Flanagan J, Karagiannides I, et al. Identification of depot-specific human fat cell progenitors through distinct expression profiles and developmental gene patterns. Am J Physiol Endocrinol Metab 2007; 292:E298-307; PMID:16985259; http://dx.doi.org/10.1152/ajpendo.00202.2006
   PubMed Web of Science ®Google Scholar
• Franco-Pons N, Gea-Sorli S, Closa D. Release of inflammatory mediators by adipose tissue during acute pancreatitis. J Pathol 2010; 221:175-82; PMID:20217859; http://dx.doi.org/10.1002/path.2691
   PubMed Web of Science ®Google Scholar
• Heni M, Machann J, Staiger H, Schwenzer NF, Peter A, Schick F, Claussen CD, Stefan N, Häring HU, Fritsche A. Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes/Metab Res Rev 2010; 26:200-5; http://dx.doi.org/10.1002/dmrr.1073
   PubMed Web of Science ®Google Scholar
• Rippe C, Berger K, Mei J, Lowe ME, Erlanson-Albertsson C. Effect of long-term high-fat feeding on the expression of pancreatic lipases and adipose tissue uncoupling proteins in mice. Pancreas 2003; 26:e36-42; PMID:12604926; http://dx.doi.org/10.1097/00006676-200303000-00024
   PubMedGoogle Scholar
• Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G, Rothenberg FG, Neltner B, Romig-Martin SA, Dickson EW, et al. Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding. Circ Res 2009; 104:541-9; PMID:19122178; http://dx.doi.org/10.1161/CIRCRESAHA.108.182998
   PubMed Web of Science ®Google Scholar
• Wang J, Tsai S, Shameli A, Yamanouchi J, Alkemade G, Santamaria P. In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation. Proc Natl Acad Sci U S A 2010; 107:9317-22; PMID:20439719; http://dx.doi.org/10.1073/pnas.0913835107
   PubMed Web of Science ®Google Scholar
• Pihoker C, Gilliam LK, Hampe CS, Lernmark A. Autoantibodies in diabetes. Diabetes 2005; 54 Suppl 2:S52-61; PMID:16306341; http://dx.doi.org/10.2337/diabetes.54.suppl_2.S52
   PubMedGoogle Scholar
• van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011; 91:79-118; PMID:21248163; http://dx.doi.org/10.1152/physrev.00003.2010
   PubMed Web of Science ®Google Scholar
• Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53:693-700; PMID:14988254; http://dx.doi.org/10.2337/diabetes.53.3.693
   PubMed Web of Science ®Google Scholar
• Shao L, Zhou HJ, Zhang H, Qin L, Hwa J, Yun Z, Ji W, Min W. SENP1-mediated NEMO deSUMOylation in adipocytes limits inflammatory responses and type-1 diabetes progression. Nat Commun 2015; 6:8917; PMID:26596471; http://dx.doi.org/10.1038/ncomms9917
   PubMed Web of Science ®Google Scholar
• Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 1999; 189:331-9; PMID:9892615; http://dx.doi.org/10.1084/jem.189.2.331
   PubMed Web of Science ®Google Scholar
• Akirav E, Kushner JA, Herold KC. Beta-cell mass and type 1 diabetes: going, going, gone? Diabetes 2008; 57:2883-8; PMID:18971435; http://dx.doi.org/10.2337/db07-1817
   PubMed Web of Science ®Google Scholar
• Carvalho-Pinto C, García MI, Gómez L, Ballesteros A, Zaballos A, Flores JM, Mellado M, Rodríguez-Frade JM, Balomenos D, Martínez AC. Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur J Immunol 2004; 34:548-57; PMID:14768060; http://dx.doi.org/10.1002/eji.200324285
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bandala-Sanchez E, Harrison LC. Revisiting regulatory T cells in type 1 diabetes. Curr Opin Endocrinol Diabetes Obesity 2012; 19:271-8; http://dx.doi.org/10.1097/MED.0b013e328355a2d5
   PubMed Web of Science ®Google Scholar
• Li SJ, Hochstrasser M. A new protease required for cell-cycle progression in yeast. Nature 1999; 398:246-51; PMID:10094048; http://dx.doi.org/10.1038/18457
   PubMed Web of Science ®Google Scholar
• Gill G. SUMO and ubiquitin in the nucleus: different functions, similar mechanisms? Genes Dev 2004; 18:2046-59; PMID:15342487; http://dx.doi.org/10.1101/gad.1214604
   PubMed Web of Science ®Google Scholar
• Li M, Guo D, Isales CM, Eizirik DL, Atkinson M, She JX, Wang CY. SUMO wrestling with type 1 diabetes. J Mol Med (Berl) 2005; 83:504-13; PMID:15806321; http://dx.doi.org/10.1007/s00109-005-0645-5
   PubMed Web of Science ®Google Scholar
• Guo D, Li M, Zhang Y, Yang P, Eckenrode S, Hopkins D, Zheng W, Purohit S, Podolsky RH, Muir A, et al. A functional variant of SUMO4, a new I kappa B α modifier, is associated with type 1 diabetes. Nat Genet 2004; 36:837-41; PMID:15247916; http://dx.doi.org/10.1038/ng1391
   PubMed Web of Science ®Google Scholar
• Aribi M. Candidate genes implicated in type 1 diabetes susceptibility. Curr Diabetes Rev 2008; 4:110-21; PMID:18473758; http://dx.doi.org/10.2174/157339908784220723
   PubMedGoogle Scholar
• Wang CY, Podolsky R, She JX. Genetic and functional evidence supporting SUMO4 as a type 1 diabetes susceptibility gene. Ann N Y Acad Sci 2006; 1079:257-67; PMID:17130563; http://dx.doi.org/10.1196/annals.1375.039
   PubMed Web of Science ®Google Scholar
• Hayashi T, Faustman D. NOD mice are defective in proteasome production and activation of NF-kappaB. Mol Cell Biol 1999; 19:8646-59; PMID:10567588; http://dx.doi.org/10.1128/MCB.19.12.8646
   PubMed Web of Science ®Google Scholar
• Mabb AM, Miyamoto S. SUMO and NF-kappaB ties. Cell Mol Life Sci 2007; 64:1979-96; PMID:17530464; http://dx.doi.org/10.1007/s00018-007-7005-2
   PubMed Web of Science ®Google Scholar
• Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003; 115:565-76; PMID:14651848; http://dx.doi.org/10.1016/S0092-8674(03)00895-X
   PubMed Web of Science ®Google Scholar
• Lee MH, Mabb AM, Gill GB, Yeh ET, Miyamoto S. NF-kappaB induction of the SUMO protease SENP2: A negative feedback loop to attenuate cell survival response to genotoxic stress. Mol Cell 2011; 43:180-91; PMID:21777808; http://dx.doi.org/10.1016/j.molcel.2011.06.017
   PubMed Web of Science ®Google Scholar
• Qiao Z, Wang W, Wang L, Wen D, Zhao Y, Wang Q, Meng Q, Chen G, Wu Y, Zhou H. Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors. Bioorg Med Chem Lett 2011; 21:6389-92; PMID:21930380; http://dx.doi.org/10.1016/j.bmcl.2011.08.101
   PubMed Web of Science ®Google Scholar
• Chen X, Lu J, Bao J, Guo J, Shi J, Wang Y. Adiponectin: A biomarker for rheumatoid arthritis? Cytokine Growth Factor Rev 2012; 24(1):83-9; PMID:22910140; http://dx.doi.org/10.1016/j.cytogfr.2012.07.004
   PubMed Web of Science ®Google Scholar
• Madu IG, Chen Y. Assays for investigating deSUMOylation enzymes. Curr Protoc Mol Biol 2012; Chapter 10, Unit10. 30: 1-13; PMID:22870856
   PubMedGoogle Scholar